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Organophosphates with the general structure XP<R2, where R1 and R2 are substituent O(S) groups referred to below and X is an organic or inorganic acid residue, are widely used as insecticides. Information concerning their mechanism of action is mainly based on results obtained with compounds which are per se effective and have as R1 an alkoxy group, and as R2 an alkoxy, alkyl or dialkylamido group. To this group (group 1) belong dialkylphosphates, e.g. tetraethyl pyrophosphate (TEPP), diethyl-4-nitrophenylphosphate (Paraoxon) and diisopropyl phosphorofluoridate (DFP), isopropyl methylphosphonofluoridate (Sarin) and ethyl-N-dimethylphosphoramidocyanidate (Tabun).
Many of the organophosphates used as insecticides nowadays have a low intrinsic toxicity but undergo metabolic activation in vivo (O'Brien 1960) . To this group (group 2) belong thioates, e.g. Demeton-methyl, Methylparathion and Malathion (R1= R2: OCH3), and Systox, Demeton and Parathion (R1=R2: OC2H.). The active metabolites of thioates are their 0-analogues, e.g. Parathion --+ diethyl-4-nitrophenylphosphate. Compounds with a dialkylamido group, e.g. Dimefox or OMPA (R1=R2: N(CH3)2), are converted into their N-oxide.
Organophosphates inhibit mammalian acetylcholinesterase. The reaction between acetylcholinesterase and organophosphates (group 1 or metabolites of group 2) is analogous to that between acetylcholinesterase and acetylcholine and yields phosphorylated acetylcholinesterase. Phosphorylated acetylcholinesterase, however, is much more stable than acetylated acetylcholinesterase and its spontaneous reactivation by water is the rate-determining step in the reaction. Spontaneous reactivation of dimethyl phosphorylacetylcholinesterase at 37°C and pH 7 5 amounts to 50 % in 90 min (Aldridge & Davison 1953) . Diethyl phosphorylacetylcholinesterase is approximately twenty times more stable (Burgen & Hobbiger 1951) and no spontaneous reactivation can be demonstrated with diisopropyl phosphorylacetylcholinesterase or the phosphorylated acetylcholinesterases formed by Sarin or Tabun.
Organophosphates by inhibiting acetylcholinesterase by phosphorylation cause an accumulation of acetylcholine and their administration is followed by the typical muscarinic and nicotinic symptoms of acetylcholine poisoning. Acute death in organophosphate poisoning is due to respiratory failure resulting from paralysis of respiratory muscles or of the respiratory centre, from bronchoconstriction and excessive bronchial secretion or from a combination of these effects. Impaired circulation undoubtedly is a contributory factor. The exact nature of respiratory failure varies with species and organophosphate (Holmes 1953) .
Atropine supported by artificial respiration and clearance of the air passages acts as an antidote in organophosphate poisoning. An alternative approach is based on reactivation of phosphorylated acetylcholinesterase. The most potent reactivators are oximes and the following, listed in the order of increasing potency, have been investigated extensively: monoisonitrosoacetone (MINA), various salts of N-mnethyl pyridine-2aldoxiine (its iodide is known as P-2-AM, 2-PAM or PAM), and N,N'-trimethylenebis (pyridine-4-aldoxime bromide).
Phosphorylated acetylcholinesterases which can be reactivated by oximes are those types which are formed initially with dialkylphosphates, Sarin or Tabun. In the case of quatemnary pyridine aldoximes the rate of reactivation follows the order diethyl phosphorylacetylcholinesterases> ditnethyl phosphorylacetylcholinesterase, phosphorylated acetylcholinesterase formed by Sarin> diisopropyl phosphorylacetylcholinesterase > 9 403 phosphorylated acetylcholinesterase formed by Tabun. Reactivation has a distinct pH optimum because the active species of an oxime is its anion, and reactivation can only take place if an acidic group at the esteratic site of the enzyme is protonated. Reactivation by MINA and quaternary pyridine aldoximes also involves the formation of a complex between anion of the oxime and phosphorylated acetylcholinesterase and the better the orientation between the two the more readily reactivation occurs. It is for this reason that at pH 7-5 the relative reactivating potencies for diethyl phosphorylacetylcholinesterase, taking that of P-2-AM as 1, are 0-1 for MINA (Davies & Green 1956), and 22 for N,N'-trimethylenebis (pyridine-4-aldoxime bromide) (Hobbiger et al. 1960) . At pH 7-5 and 37°C 0-012 mM P-2-AM reactivates 50% of diethyl phosphorylacetylcholinesterase in 20 min (Hobbiger et al. 1960 ). On ageing phosphorylated acetylcholinesterase is converted into a non-reactivatable formn. The loss of reactivatability probably is attributable to the loss of one alkyl group from the phosphorylated enzyme. The rates of formnation of a nonreactivatable phosphorylated acetylcholinesterase at 370C and pH 7-5 are three hours for diisopropyl phosphorylacetylcholinesterase, six hours for the dimethyl derivative and > 24 hours for the diethyl derivative (Hobbiger 1956, and unpublished) . The phosphorylated acetylcholinesterase formed by Sarin behaves like diisopropyl phosphorylacetylcholinesterase (Davies & Green 1956) and that formed by Tabun undergoes ageing more rapidly than any other type (I Enander 1960, unpublished) .
MINA and quaternary pyridine aldoximes, given in amounts which themselves are well tolerated, lower the toxicity of those organophosphates which initially form a reactivatable phosphorylated acetylcholinesterase. A single dose of 0-1 m. mole/kg of N,N'-trimethylenebis (pyridine-4-aldoxime bromide), given 5 to 10 ninutes before the organophosphate, raises the LD50 of TEPP and DFP in mice 20and 5-fold respectively (Hobbiger & Sadler 1959) whereas 0 4 m. mole/kg MINA under similar conditions raises the LD50 of Sarin in rats 4to 5-fold (Askew 1957) .
The antidotal activity of quaternary pyridine aldoximes is greatly increased by atropine. In inice injected prophylactically with 0-1 m. mole/kg P-2-AM, 0-15 m. mole/kg atropine or a combination of both, the LD50 of TEPP is rasied 2-, 1to 2-and 32-fold respectively (Hobbiger 1957) . The type of phosphorylated acetylcholinesterase which is formed is not the sole factor which determines the antidotal activity of P-2-AM since it is not the same for all organophosphates which are per se phosphorylating agents and form diethyl phosphorylacetylcholinesterase (Hobbiger 1957) .
Studies of the relationship between antidotal action of oximes in poisoning by dialkylphosphates, Sarin or Tabun and reactivation of phosphorylated acetylcholinesterase have yielded the following information:
(1) Reactivation of phosphorylated acetylcholinesterases formed by dialkylphosphates (Hobbiger 1957 , Koelle 1957 and Sarin (Rutland 1958) occurs together with antidotal action.
(2) In TEPP poisoning a good correlation exists between antidotal activity of quaternary pyridine aldoximes and their reactivating potency (Berry et al. 1959) . Differences between rates of penetration of oximes into brain probably account for the finding that the lipid-insoluble P-2-AM is less effective than the lipid-soluble MINA in preventing poisoning by Sarin, while the reverse applies to their reactivating potencies in vitro (Hobbiger 1957 , Rutland 1958 . This interpretation is supported by the finding that lipid-soluble oximes potentiate the antidotal activity of P-2-AM (Wilson 1958) .
(3) Oximes have little or no antidotal activity in poisoning by organophosphates which form a non-reactivatable phosphorylated acetylcholinesterase.
(4) Pyridine-2-aldoxime methiodide, in conventional doses, does not raise the LD50 of physostigmine or neostigtnine and N,N'-trimethylenebis (pyridine-4-aldoxime bromnide) does so only to a small extent (Hobbiger & Sadler 1959 ). (5) Antidotal activity of oximes and their ability to hydrolyse organophosphates, to inhibit acetylcholinesterase or to exert other actions, e.g. to block actions of acetylcholine or to reactivate phosphorylated hydrolytic enzymes in general, are unrelated.
These findings indicate that reactivation ofphosphorylated acetylcholinesterase plays an essential part in the antidotal action of MINA and quaternary pyridine aldoximes against dialkylphosphates, Sarin and Tabun but that at least in some cases other actions of the oximes might contribute to it.
The half-life of oximes in vivo is short and their antidotal activity is greatest when they are given prophylactically. Their therapeutic usefulness is limited by the speedy onset of death when lethal doses of organophosphates of group 1 are given; in the case of organophosphates of group 2 more time is available for therapeutic treatment and repeated administration of the oximes gives the best results.
The only oximne so far used in man is P-2-AM which has been given in acute Parathion poisoning (Namba & Hiraki 1958 , Karlog et al. 1958 , Erdmann 1960 . During the early stages of poisoning the intravenous infusion of P-2-AM, Section ofComparative Medicine 405 in combination with atropine, speedily reverses symptoms of poisoning and reactivates phosphorylated acetylcholinesterase. When residual Parathion is left in the body after the concentration of P-2-AM has fallen below effective levels symptoms and phosphorylation return and no reactivation or improvement occurs when the phosphorylated acetylcholinesterase is of the aged type.
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The physiological effects of acute anticholinesterase poisoning are believed to be entirely due to the accumulation of acetylcholine (Holmes 1953) . These effects are seen at three main sites: (a) At neuromuscular junctions where transient overstimulation of the muscles is followed by paralysis. (b) In the brain where synaptic transmission involving acetylcholine is interrupted. This is particularly important in the respiratory centre. (c) In the autonomic nervous system where ganglionic transmission is paralysed and cholinergic nerve endings are over-stimulated. The effects at (a) and (b) are lethal as they lead to asphyxia; the autonomic effects are not lethal in themselves but are the source of most of the signs and symptoms, e.g. bronchoconstriction, salivation and sweating.
In sublethal poisoning both primary and secondary effects can be distinguished. The secondary effects are those associated with prolonged cerebral anoxia and mnay be seen in animals or men after recovery from severe poisoning. Sublethal poisoning, even without acute symptoms, may lead to delayed changes in the central nervous system with degeneration of myelinated nerve fibres in certain long nerves and spinal tracts and the later development in man and other susceptible species of the syndrome known as 'ginger paralysis', or 'organophosphorus neurotoxicity'. There is some evidence that this is not a direct anticholinesterase effect (Davies et al. 1960) .
Animals given repeated small doses over a period of weeks may develop neurotoxicity as the small doses are cumulative. Other than this there is no recognizable chronic toxicity; true anticholinesterase effects are believed to be always acute. On the other hand with repeated small doses of anticholinesterase at frequent intervals the blood, and presumably the brain cholinesterase, falls lower and lower so that the dose of anticholinesterases required to precipitate acute poisoning becomes progressively less. With this type of poisoning inhibited cholinesterase is partly replaced and partly reactivated, and the agent itself is metabolized and excreted. Animal experiments show that as much as one-third of an LD5O of certain anticholinesterases may be absorbed daily without deleterious effects.
The signs and symptoms of acute poisoning in the early stages vary with the route of entry. With the respiratory route there is bronchoconstriction, felt as a tightness in the chest, salivation and rhinorrhoea; salivation is also seen in the late stages in animals when it becomes very marked. If the eyes are exposed to an anticholinesterase vapour or become contaminated with spray or aerosol there is acute miosis; very slight traces of an anticholinesterase will produce miosis locally in this way, e.g. in the case of Sarin, exposure to 0-33 mg/cu.m for 15 minutes. In systemic poisoning, however, miosis only occurs with gross intoxication and is almost an indication that a lethal dose has been absorbed. Skin contamination may result in local fasciculation and sweating, but these signs also do not appear in systemic poisoning until late. Gastro-intestinal cramps, with deftcation, occur early with oral administration, but otherwise are indicative of severe poisoning with the absorption of a substantial fraction of a lethal dose; convulsive emptying of the bladder is also a late sign. Cardiac slowing occurs and is especially marked with the intravenous route of administration.
True clinical convulsions are not invariably seen. In animals convulsions tend to be limited and may in part be anoxic in origin. A large animal given a lethal dose of anticholinesterase gradually becomes unsteady on its feet, then gently keels over, gives a few convulsive jerks and stops breathing; a few spasmodic efforts of breathing may take place before death and there is a copious flow of saliva. At this stage the pupils will be closely constricted, and urine and fieces may be passed. The course of death in untreated anticholinesterase poisoning in man has rarely been described; in insecticide accidents men have either been found dead or in extremis or else they
